Quality of life and chronotherapy

Chronobiology International

Volumn 19, Issue 1, 2002, Pages 299-312

  Pugliese, P ^a   Garufi, C ^a   Perrone, M ^a   Aschelter, A M ^a   Zappala A ^a   Terzoli, E ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chronomodulated therapy; Circadian rhythms; Colon cancer; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRINOTECAN; MITOMYCIN C; OFLOXACIN; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; COLON CANCER; HUMAN; QUALITY OF LIFE; QUESTIONNAIRE; TOXICITY; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CHRONOTHERAPY; CLINICAL TRIALS; COLORECTAL NEOPLASMS; HUMANS; QUALITY OF LIFE;

EID: 0036226152     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-120002605     Document Type: Article

References (69)

1. Measuring health related quality of life
2. Assessment of quality of life outcomes
3. Quality of life in oncology patients
4. Aaronson what is it? how should it be measured?
5. The European Organization for the Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
6. Quality of life during and after cancer treatment
7. Advances in the measurement of functional status: Construction of aggregate indexes
8. Measuring the quality of life of cancer patients. The functional living index - Cancer: Development and validation
9. Measuring quality of life in palliative care
10. A critical appraisal of the quality of quality-of-life measurements
11. Norman assessing the usefulness of evaluative instruments
12. Bonomi 1995 update
13. Quality of life
14. Quality of life
15. The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials
16. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients
17. The EORTC breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study
18. Food and drug administration requirements for approval of new anti-cancer drugs
19. The quality of life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: Organization and functions
20. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma
21. The rights of patients in research
22. Quality-of-life assessment in cancer treatment protocols: Research issues in protocol development
23. Role of quality of life and satisfaction with care assessment
24. The Effects of a 24hour psychological training program on attitudes, communication skills and occupational stress in oncology: A randomised study
25. Quality of life assessment in clinical trials-guidelines and a checklist for protocol writers: The U.K. Medical Research Council experience
26. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
27. Expectancy or Primary Chemotherapy in Patients with Advanced Asymptomatic Colorectal Cancer A Randomised Trial
28. General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study
29. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer
30. Final results of a randomised trial comparing tomudex (Raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
31. The importance of stabilization as an endpoint in the treatment of metastatic colorectal carcinoma: Recent quality of life studies
32. Quality of life and survival with continuous ephatic-artery foxuridine infusion for colorectal liver metastases
33. Kocha a meta-analysis of randomized controlled trials
34. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
35. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
36. Rougier a multicentre randomised trial
37. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
38. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
39. Circadian cancer therapy
40. An objective measure for performance status (PS) and a strong indicator for quality of life (QL)
41. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status
42. Chronotherapy for gastrointestinal cancer
43. A Phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer
44. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: A feasibility and tolerability study
45. A Phase I trial of 5-day chronomodulated infusion of fluorouracil and L-Folinic acid in patients with metastatic colorectal cancer
46. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with metastatic colorectal cancer
47. Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (Leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
48. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
49. Psychological complications of dialysis
50. Studio della qualitá di vita nei trattamenti alternativi della insufficienza renale cronica: Dialisi e trapianto
51. Personality, inner experience and compliance in advanced cancer patients treated with external pumps
52. Variabili soggettive nei protocolli
53. Continuous infusion carboplatin on a 21-day schedule: A Phase I and pharmacokinetic study
54. An inventory for measuring depression
55. Patient's adjustment to cancer the mental adjustment to cancer (M.A.C.) scale vs clinical ratings
56. The hospital anxiety and depression scale
57. The medical team and the psychological containment during chemotherapy: The patient point of view
58. Quality of life (QoL) evaluation during infusional chronotherapy (Chrono) in advanced colorectal cancer (ACC) patients (Pts): Correlation with clinical parameters
59. Overcoming resistence to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
60. Homerin a comparison of QoL during bolus plus infusion 5-FU/leucovorin with or without oxaliplatin
61. Chronomodulated (Chrono) Infusion of 5-fluorouracil (5-FU) and L-Folinic acid (FA) in 91 Patients (pts) with metastatic colorectal cancer: The Regina Elena Cancer Institute experience
62. Irinotecan (CPT-11) and chronomodulated infusion of 5-Fluorouracil and folinic acid (CPT-11/ff16) for patients with advanced colorectal cancer: A Phase I study
63. Mitomycin-C (MMC) plus chronomodulated infusion of 5-Fluoro-uracil (5-FU) and folinic acid (FA) (MMC/FF5-16) in 46 advanced colorectal cancer (ACC) patients (PTS)
64. Comparative psychological aspects of two different types of chemotherapy administration (chronotherapy vs. traditional chemotherapy) on quality of life of cancer patients ad advanced stage
65. A preventive psychological crisis intervention (PPCI) to improve the qualità of life in reply to: Advanced colorectal cancer (ACC) patients submitted to chronotherapy